论文部分内容阅读
目的分析沙美特罗替卡松粉吸入剂联合止咳平喘丸治疗支气管哮喘的急性发作的临床效果。方法 87例哮喘急性发作的轻度、中度患者,随机分为观察组(44例)和对照组(43例)。两组患者均使用沙丁胺醇气雾剂。对照组用沙美特罗替卡松粉吸入剂,观察组在对照组基础上加服本院自制的止咳平喘丸。两组疗程均为2周。观察两组患者治疗效果及肺功能特点等。结果观察组总有效率为79.55%,明显高于对照组的48.84%,差异具有统计学意义(P<0.05);两组患者治疗后均没有不良反应发生。结论对支气管哮喘急性发作的患者采用沙美特罗替卡松粉吸入剂联合止咳平喘丸进行治疗,效果显著,且较安全,在临床上可以推广使用。
Objective To analyze the clinical effect of salmeterol and fluticasone powder inhalation combined with Cough and Relieving Pill in the treatment of acute attack of bronchial asthma. Methods A total of 87 mild to moderate asthma exacerbations were randomly divided into observation group (44 cases) and control group (43 cases). Salbutamol aerosol was used in both groups. Control group with salmeterol fluticasone powder inhalation, the observation group in the control group based on the addition of our hospital made cough asthma pills. Two groups of treatment are 2 weeks. Observation of two groups of patients with treatment and pulmonary function characteristics. Results The total effective rate in the observation group was 79.55%, which was significantly higher than that in the control group (48.84%, P <0.05). No adverse reactions occurred in both groups after treatment. Conclusion Patients with acute exacerbation of bronchial asthma treated with salmeterol and fluticasone powder inhalation combined with Zhike Pingchuan Pills were effective and safe and could be used clinically.